Naïs Prade

801 total citations
8 papers, 395 citations indexed

About

Naïs Prade is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Naïs Prade has authored 8 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Naïs Prade's work include Acute Myeloid Leukemia Research (7 papers), DNA Repair Mechanisms (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Naïs Prade is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), DNA Repair Mechanisms (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). Naïs Prade collaborates with scholars based in France, Canada and Belgium. Naïs Prade's co-authors include Éric Delabesse, Christian Récher, Cécile Demur, Stéphane Manenti, Christine Didier, Arnaud Petit, Jean Donadieu, Véronique Mansat‐De Mas, Cindy Cavelier and Nicole Dastugue and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Naïs Prade

8 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Naïs Prade France	7	197	176	95	90	78	8	395
Massimiliano De Bortoli Italy	10	183 0.9×	78 0.4×	144 1.5×	94 1.0×	60 0.8×	20	412
Bhumi Patel United States	7	150 0.8×	105 0.6×	78 0.8×	80 0.9×	30 0.4×	9	378
LC Bowman United States	6	128 0.6×	156 0.9×	153 1.6×	48 0.5×	125 1.6×	7	424
Sara Pepe Italy	9	162 0.8×	77 0.4×	97 1.0×	74 0.8×	27 0.3×	35	366
P Jonveaux France	8	195 1.0×	195 1.1×	110 1.2×	136 1.5×	70 0.9×	10	471
Norio Shiba Japan	13	284 1.4×	323 1.8×	60 0.6×	35 0.4×	80 1.0×	40	533
Satoru Kojika Japan	10	173 0.9×	138 0.8×	86 0.9×	75 0.8×	38 0.5×	15	384
Rika Kanezaki Japan	11	198 1.0×	163 0.9×	47 0.5×	68 0.8×	48 0.6×	19	387
Alexandria Petrusich United States	6	301 1.5×	166 0.9×	173 1.8×	31 0.3×	33 0.4×	7	449
Carl Sandén Sweden	11	198 1.0×	187 1.1×	91 1.0×	137 1.5×	23 0.3×	18	426

Countries citing papers authored by Naïs Prade

Since Specialization

Citations

This map shows the geographic impact of Naïs Prade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naïs Prade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naïs Prade more than expected).

Fields of papers citing papers by Naïs Prade

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naïs Prade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naïs Prade. The network helps show where Naïs Prade may publish in the future.

Co-authorship network of co-authors of Naïs Prade

This figure shows the co-authorship network connecting the top 25 collaborators of Naïs Prade. A scholar is included among the top collaborators of Naïs Prade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naïs Prade. Naïs Prade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Bories, Pierre, Naïs Prade, Bastien Cabarrou, et al.. (2020). Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine. PLoS ONE. 15(10). e0238795–e0238795. 13 indexed citations

2.

Largeaud, Laëtitia, Emilie Bérard, Sarah Bertoli, et al.. (2019). Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors. Leukemia Research. 81. 82–87. 6 indexed citations

3.

Fernandez-Vidal, Anne, Sarah Bertoli, Srđana Grgurević, et al.. (2016). CHK1 as a therapeutic target to bypass chemoresistance in AML. Science Signaling. 9(445). ra90–ra90. 58 indexed citations

4.

Ballerini, Paola, Stéphanie Struski, Naïs Prade, et al.. (2012). RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation. Leukemia. 26(11). 2384–2389. 81 indexed citations

5.

Lagarrigue, Frédéric, Laurence Lamant, Naïs Prade, et al.. (2012). ALK+ALCLs induce cutaneous, HMGB-1–dependent IL-8/CXCL8 production by keratinocytes through NF-κB activation. Blood. 119(20). 4698–4707. 25 indexed citations

6.

Pasquet, Marlène, Christine Bellanné‐Chantelot, Suzanne Tavitian, et al.. (2012). High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood. 121(5). 822–829. 126 indexed citations

7.

Quelen, Cathy, Éric Lippert, Stéphanie Struski, et al.. (2011). Identification of a transforming MYB-GATA1 fusion gene in acute basophilic leukemia: a new entity in male infants. Blood. 117(21). 5719–5722. 29 indexed citations

8.

Cavelier, Cindy, Christine Didier, Naïs Prade, et al.. (2009). Constitutive Activation of the DNA Damage Signaling Pathway in Acute Myeloid Leukemia with Complex Karyotype: Potential Importance for Checkpoint Targeting Therapy. Cancer Research. 69(22). 8652–8661. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact